Hydroxocobalamin Uptake into the Cerebrospinal Fluid after Nasal and Intravenous Delivery in Rats and Humans
- 1 July 2003
- journal article
- research article
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 11 (6) , 325-331
Abstract
The possibility of direct transport of hydroxocobalamin from the nasal cavity into the cerebrospinal fluid (CSF) after nasal administration in rats was investigated and the results were compared with a human study. Hydroxocobalamin was given to rats (n=8) both intranasally (214 μg/rat) and intravenously (49.5 μg/rat) into the jugular vein using a Vascular Access Port (VAP). Prior to and after drug administration, blood and CSF samples were taken and analysed by radioimmunoassay. The AUCCSF/AUCplasma ratio after nasal delivery does not differ from the ratio after intravenous infusion, indicating that hydroxocobalamin enters the CSF via the blood circulation across the blood–brain barrier (BBB). This same transport route is confirmed by the cumulative AUC-time profiles in CSF and plasma, demonstrating a 30 min delay between plasma absorption and CSF uptake of hydroxocobalamin in rats and in a comparative human study. The present results in rats show that there is no additional uptake of hydroxocobalamin in the CSF after nasal delivery compared to intravenous administration, which is in accordance with the results found in humans. This indicates a predictive value of the used rat model for the human situation when studying the nose to CSF transport of drugs.Keywords
This publication has 24 references indexed in Scilit:
- Sniffing neuropeptides: a transnasal approach to the human brainNature Neuroscience, 2002
- Classification of Cilio‐Inhibiting Effects of Nasal DrugsThe Laryngoscope, 2001
- The distribution of local anesthetics into the CSF following intranasal administrationInternational Journal of Pharmaceutics, 1998
- Nasal absorption of hydroxocobalamin in healthy elderly adultsBritish Journal of Clinical Pharmacology, 1998
- Nasal Route for Direct Delivery of Solutes to the Central Nervous System: Fact or Fiction?Journal of Drug Targeting, 1998
- Intranasal Absorption of the Platelet Glycoprotein IIb/IIIa Receptor Antagonist, DMP 755, and the Effect of Anesthesia on Nasal BioavailabilityJournal of Pharmaceutical Sciences, 1997
- Investigation of the effect of anaesthesia on nasal absorption of insulin in ratsInternational Journal of Pharmaceutics, 1997
- A nose-brain pathway for psychotropic peptides: evidence from a brain evoked potential study with cholecystokininPsychoneuroendocrinology, 1996
- Nasal Absorption of Zidovudine and Its Transport to Cerebrospinal Fluid in Rats.Biological and Pharmaceutical Bulletin, 1994
- Nasal administration of a cognition enhancer provides improved bioavailability but not enhanced brain deliveryJournal of Pharmaceutical Sciences, 1990